tiprankstipranks
Trending News
More News >
Hca Healthcare (HCA)
:HCA
US Market

HCA Healthcare (HCA) Stock Forecast & Price Target

Compare
1,666 Followers
See the Price Targets and Ratings of:

HCA Analyst Ratings

Moderate Buy
12Ratings
Moderate Buy
8 Buy
4 Hold
0 Sell
Based on 12 analysts giving stock ratings to
HCA
Healthcare
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

HCA Stock 12 Month Forecast

Average Price Target

$382.30
▲(0.04%Upside)
Based on 12 Wall Street analysts offering 12 month price targets for HCA Healthcare in the last 3 months. The average price target is $382.30 with a high forecast of $444.00 and a low forecast of $336.00. The average price target represents a 0.04% change from the last price of $382.16.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"298":"$298","445":"$445","334.75":"$334.8","371.5":"$371.5","408.25":"$408.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":444,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$444.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":382.3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$382.30</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":336,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$336.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[298,334.75,371.5,408.25,445],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,343.04,350.80615384615385,358.57230769230773,366.33846153846156,374.1046153846154,381.87076923076927,389.6369230769231,397.4030769230769,405.1692307692308,412.93538461538463,420.70153846153846,428.46769230769235,436.2338461538462,{"y":444,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,343.04,346.06,349.08000000000004,352.1,355.12,358.14000000000004,361.16,364.18,367.2,370.22,373.24,376.26,379.28000000000003,{"y":382.3,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,343.04,342.4984615384616,341.9569230769231,341.41538461538465,340.87384615384616,340.3323076923077,339.79076923076923,339.2492307692308,338.7076923076923,338.16615384615386,337.62461538461537,337.08307692307693,336.54153846153844,{"y":336,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":306.98,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":337.05,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":313.22,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":360.93,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":393.2,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":403.68,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":355.63,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":326.2,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":299.47,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":329.17,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":305.61,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":345.73,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":343.04,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$444.00Average Price Target$382.30Lowest Price Target$336.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays
$366$416
Buy
8.85%
Upside
Reiterated
06/03/25
HCA Healthcare price target raised to $416 from $366 at BarclaysHCA Healthcare price target raised to $416 from $366 at Barclays
Wells Fargo Analyst forecast on HCA
Stephen BaxterWells Fargo
Wells Fargo
$320$385
Hold
0.74%
Upside
Upgraded
05/29/25
Analysts Offer Insights on Healthcare Companies: Veeva Systems (NYSE: VEEV) and HCA Healthcare (NYSE: HCA)
Cantor Fitzgerald Analyst forecast on HCA
Sarah JamesCantor Fitzgerald
Cantor Fitzgerald
$444
Buy
16.18%
Upside
Reiterated
05/28/25
HCA Healthcare (HCA) Gets a Buy from Cantor Fitzgerald
Bank of America Securities Analyst forecast on HCA
Joanna GajukBank of America Securities
Bank of America Securities
Buy
Reiterated
05/19/25
Bank of America Securities Remains a Buy on HCA Healthcare (HCA)
Truist Financial Analyst forecast on HCA
David S MacdonaldTruist Financial
Truist Financial
$390
Buy
2.05%
Upside
Reiterated
04/28/25
Analysts Conflicted on These Healthcare Names: HCA Healthcare (NYSE: HCA), Edwards Lifesciences (NYSE: EW) and Gilead Sciences (NASDAQ: GILD)
Morgan Stanley Analyst forecast on HCA
Craig HettenbachMorgan Stanley
Morgan Stanley
$355
Hold
-7.11%
Downside
Reiterated
04/28/25
HCA Healthcare: Balanced Risk/Reward Profile Justifies Hold Rating Amid Strong Performance and High Valuation
Leerink Partners Analyst forecast on HCA
Whit MayoLeerink Partners
Leerink Partners
$390
Buy
2.05%
Upside
Reiterated
04/28/25
HCA Healthcare: Strong Performance and Growth Potential Amidst Challenges
KeyBanc
$370
Buy
-3.18%
Downside
Reiterated
04/28/25
KeyBanc Keeps Their Buy Rating on HCA Healthcare (HCA)
TD Cowen
$377$361
Buy
-5.54%
Downside
Reiterated
04/28/25
HCA Healthcare: Strong Financial Performance and Strategic Initiatives Drive Buy Rating
RBC Capital Analyst forecast on HCA
Ben HendrixRBC Capital
RBC Capital
$376
Buy
-1.61%
Downside
Reiterated
04/27/25
HCA Healthcare (HCA) Gets a Buy from RBC Capital
Robert W. Baird Analyst forecast on HCA
Michael HaRobert W. Baird
Robert W. Baird
$396$336
Hold
-12.08%
Downside
Downgraded
04/14/25
HCA Healthcare downgraded to Neutral from Outperform at BairdHCA Healthcare downgraded to Neutral from Outperform at Baird
Guggenheim Analyst forecast on HCA
Jason CassorlaGuggenheim
Guggenheim
Hold
Initiated
04/08/25
Guggenheim starts HCA Healthcare Inc (HCA) at NeutralGuggenheim analyst Jason Cassorla initiates coverage on HCA Healthcare Inc (NYSE: HCA) with a Neutral rating.
Mizuho Securities Analyst forecast on HCA
Ann HynesMizuho Securities
Mizuho Securities
$425
Buy
11.21%
Upside
Reiterated
02/27/25
Analysts Are Bullish on Top Healthcare Stocks: HCA Healthcare (HCA), Kura Oncology (KURA)We hosted a Fireside chat with HCA CFO Michael Marks. Key takeaways from our call include: 1) the outlook in Washington was a key investor focus, 2) HCA believes 2025 guidance fully captures all potential outcomes, 3) base underlying demand trends remain solid and pricing should continue to be strong in 2025, and 4) HCA’s strong balance sheet and cash flow continue to provide financial optionality going forward. We continue to believe earnings visibility remains high for 2025. We are reiterating our Outperform rating. Key Topic. The Washington outlook was a key focus given the potential for healthcare to be a pay-for in the upcoming tax reforms.
J.P. Morgan Analyst forecast on HCA
Benjamin RossiJ.P. Morgan
J.P. Morgan
$380$360
Hold
-5.80%
Downside
Reiterated
01/31/25
HCA Healthcare (HCA) Receives a Hold from J.P. Morgan
Jefferies
$400
Buy
4.67%
Upside
Reiterated
01/29/25
HCA Healthcare: Strong Financial Performance and Strategic Management Justify Buy Rating
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays
$366$416
Buy
8.85%
Upside
Reiterated
06/03/25
HCA Healthcare price target raised to $416 from $366 at BarclaysHCA Healthcare price target raised to $416 from $366 at Barclays
Wells Fargo Analyst forecast on HCA
Stephen BaxterWells Fargo
Wells Fargo
$320$385
Hold
0.74%
Upside
Upgraded
05/29/25
Analysts Offer Insights on Healthcare Companies: Veeva Systems (NYSE: VEEV) and HCA Healthcare (NYSE: HCA)
Cantor Fitzgerald Analyst forecast on HCA
Sarah JamesCantor Fitzgerald
Cantor Fitzgerald
$444
Buy
16.18%
Upside
Reiterated
05/28/25
HCA Healthcare (HCA) Gets a Buy from Cantor Fitzgerald
Bank of America Securities Analyst forecast on HCA
Joanna GajukBank of America Securities
Bank of America Securities
Buy
Reiterated
05/19/25
Bank of America Securities Remains a Buy on HCA Healthcare (HCA)
Truist Financial Analyst forecast on HCA
David S MacdonaldTruist Financial
Truist Financial
$390
Buy
2.05%
Upside
Reiterated
04/28/25
Analysts Conflicted on These Healthcare Names: HCA Healthcare (NYSE: HCA), Edwards Lifesciences (NYSE: EW) and Gilead Sciences (NASDAQ: GILD)
Morgan Stanley Analyst forecast on HCA
Craig HettenbachMorgan Stanley
Morgan Stanley
$355
Hold
-7.11%
Downside
Reiterated
04/28/25
HCA Healthcare: Balanced Risk/Reward Profile Justifies Hold Rating Amid Strong Performance and High Valuation
Leerink Partners Analyst forecast on HCA
Whit MayoLeerink Partners
Leerink Partners
$390
Buy
2.05%
Upside
Reiterated
04/28/25
HCA Healthcare: Strong Performance and Growth Potential Amidst Challenges
KeyBanc
$370
Buy
-3.18%
Downside
Reiterated
04/28/25
KeyBanc Keeps Their Buy Rating on HCA Healthcare (HCA)
TD Cowen
$377$361
Buy
-5.54%
Downside
Reiterated
04/28/25
HCA Healthcare: Strong Financial Performance and Strategic Initiatives Drive Buy Rating
RBC Capital Analyst forecast on HCA
Ben HendrixRBC Capital
RBC Capital
$376
Buy
-1.61%
Downside
Reiterated
04/27/25
HCA Healthcare (HCA) Gets a Buy from RBC Capital
Robert W. Baird Analyst forecast on HCA
Michael HaRobert W. Baird
Robert W. Baird
$396$336
Hold
-12.08%
Downside
Downgraded
04/14/25
HCA Healthcare downgraded to Neutral from Outperform at BairdHCA Healthcare downgraded to Neutral from Outperform at Baird
Guggenheim Analyst forecast on HCA
Jason CassorlaGuggenheim
Guggenheim
Hold
Initiated
04/08/25
Guggenheim starts HCA Healthcare Inc (HCA) at NeutralGuggenheim analyst Jason Cassorla initiates coverage on HCA Healthcare Inc (NYSE: HCA) with a Neutral rating.
Mizuho Securities Analyst forecast on HCA
Ann HynesMizuho Securities
Mizuho Securities
$425
Buy
11.21%
Upside
Reiterated
02/27/25
Analysts Are Bullish on Top Healthcare Stocks: HCA Healthcare (HCA), Kura Oncology (KURA)We hosted a Fireside chat with HCA CFO Michael Marks. Key takeaways from our call include: 1) the outlook in Washington was a key investor focus, 2) HCA believes 2025 guidance fully captures all potential outcomes, 3) base underlying demand trends remain solid and pricing should continue to be strong in 2025, and 4) HCA’s strong balance sheet and cash flow continue to provide financial optionality going forward. We continue to believe earnings visibility remains high for 2025. We are reiterating our Outperform rating. Key Topic. The Washington outlook was a key focus given the potential for healthcare to be a pay-for in the upcoming tax reforms.
J.P. Morgan Analyst forecast on HCA
Benjamin RossiJ.P. Morgan
J.P. Morgan
$380$360
Hold
-5.80%
Downside
Reiterated
01/31/25
HCA Healthcare (HCA) Receives a Hold from J.P. Morgan
Jefferies
$400
Buy
4.67%
Upside
Reiterated
01/29/25
HCA Healthcare: Strong Financial Performance and Strategic Management Justify Buy Rating
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering HCA Healthcare

1 Month
xxx
Success Rate
25/36 ratings generated profit
69%
Average Return
+4.36%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 69.44% of your transactions generating a profit, with an average return of +4.36% per trade.
3 Months
xxx
Success Rate
28/38 ratings generated profit
74%
Average Return
+7.84%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 73.68% of your transactions generating a profit, with an average return of +7.84% per trade.
1 Year
Ben HendrixRBC Capital
Success Rate
18/19 ratings generated profit
95%
Average Return
+26.73%
reiterated a buy rating last month
Copying Ben Hendrix's trades and holding each position for 1 Year would result in 94.74% of your transactions generating a profit, with an average return of +26.73% per trade.
2 Years
xxx
Success Rate
41/41 ratings generated profit
100%
Average Return
+51.83%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +51.83% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HCA Analyst Recommendation Trends

Rating
Jan 25
Feb 25
Mar 25
Apr 25
May 25
Strong Buy
1
1
0
0
0
Buy
17
16
18
13
15
Hold
11
9
5
3
5
Sell
2
1
1
1
0
Strong Sell
0
0
0
0
0
total
31
27
24
17
20
In the current month, HCA has received 15 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. HCA average Analyst price target in the past 3 months is 382.30.
Each month's total comprises the sum of three months' worth of ratings.

HCA Financial Forecast

HCA Earnings Forecast

Next quarter’s earnings estimate for HCA is $6.26 with a range of $5.60 to $6.59. The previous quarter’s EPS was $6.45. HCA beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year HCA has Outperformed its overall industry.
Next quarter’s earnings estimate for HCA is $6.26 with a range of $5.60 to $6.59. The previous quarter’s EPS was $6.45. HCA beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year HCA has Outperformed its overall industry.

HCA Sales Forecast

Next quarter’s sales forecast for HCA is $18.49B with a range of $18.16B to $18.85B. The previous quarter’s sales results were $18.32B. HCA beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.34% of the time in the same period. In the last calendar year HCA has Outperformed its overall industry.
Next quarter’s sales forecast for HCA is $18.49B with a range of $18.16B to $18.85B. The previous quarter’s sales results were $18.32B. HCA beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.34% of the time in the same period. In the last calendar year HCA has Outperformed its overall industry.

HCA Stock Forecast FAQ

What is HCA’s average 12-month price target, according to analysts?
Based on analyst ratings, Hca Healthcare’s 12-month average price target is 382.30.
    What is HCA’s upside potential, based on the analysts’ average price target?
    Hca Healthcare has 0.04% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is HCA a Buy, Sell or Hold?
          Hca Healthcare has a consensus rating of Moderate Buy which is based on 8 buy ratings, 4 hold ratings and 0 sell ratings.
            What is Hca Healthcare’s price target?
            The average price target for Hca Healthcare is 382.30. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $444.00 ,the lowest forecast is $336.00. The average price target represents 0.04% Increase from the current price of $382.16.
              What do analysts say about Hca Healthcare?
              Hca Healthcare’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of HCA?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis